Web-based Management of Female Stress Urinary Incontinence

February 16, 2022 updated by: Eva Samuelsson, Umeå University

Web-based Management of Female Stress Urinary Incontinence. Evaluation of a Treatment Programme With Pelvic Floor Muscle Training and Elements of Cognitive Behavioural Therapy

The purpose of this study is to determine whether treatment of female stress urinary incontinence using a web-based programme is effective.

Study Overview

Detailed Description

Female urinary incontinence is very common and affects up to one fourth of grownup women. It may reduce quality of life for those affected and costs for society are high. The most common type of urinary incontinence is stress urinary incontinence (SUI), i.e leakage when coughing, sneezing or jumping. There is no association between SUI and serious medical conditions. Thus investigation can be kept to a minimum, including structured history taking and a bladder diary for correct diagnosis. Treatment with lifestyle intervention and pelvic floor muscle training (PFMT) give improvement or cure in 60-70% of women. A small study indicates that treatment with cognitive behavioural therapy (CBT) may improve incontinence-related quality of life and symptoms of urinary incontinence. Web-based management of SUI has as far as we know never been evaluated in a randomized controlled study. The aim of this study is to determine if web-based management of female SUI, with a treatment using PFMT and elements of CBT is effective compared to treatment supported by a pamphlet. The duration of the treatment programme is three months, follow-up at four months, 1 year and two years.

Study Type

Interventional

Enrollment (Actual)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Umeå, Sweden, S-90185
        • Umea University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • stress urinary incontinence
  • leakage once a week or more often
  • ability to read and write Swedish
  • asset to computer with Internet connection

Exclusion Criteria:

  • pregnancy
  • former incontinence surgery
  • known malignancy in lower abdomen
  • difficulties with passing urine
  • visual blood in urine
  • intermenstrual bleeding
  • severe psychiatric diagnosis
  • neurological disease with affection on sensibility in legs or lower abdomen

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Web-based treatment
Web-based treatment with information (including life style), PFMT, elements of CBT and regular mail contact with an urotherapist
125 women with stress urinary incontinence(SUI) participate in web-based treatment for 3 months. Treatment consists of information, PFMT and uses elements of CBT. It includes regular email contact with urotherapist.
Active Comparator: Pamphlet treatment
Information (including life style), and PFMT exercises.
125 women with SUI receive a pamphlet with information and a programme for PFMT.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)
Time Frame: baseline, 4 months
summed symptom-score, range 0-21, with higher scores indicating greater severity.
baseline, 4 months
International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)
Time Frame: baseline, 4 months
condition-specific quality of life, summed score, range 19-76, higher scores indicate greater impact on quality of life.
baseline, 4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EuroQol Five Dimensions Visual Analogue Scale (EQ5D-VAS)
Time Frame: baseline, 4 months
health-specific quality of life, range 0-100, higher scores indicate better quality of life.
baseline, 4 months
Usage of Incontinence Aids
Time Frame: baseline, 4 months
Only those using incontinence aids at baseline were included in the analysis.
baseline, 4 months
Patient Satisfaction
Time Frame: 4 months
4 months
Incontinence Episode Frequency (IEF)
Time Frame: baseline, 4 months
number of incontinence episodes per week
baseline, 4 months
Patient's Global Impression of Improvement Scale (PGI-I)
Time Frame: 4 months
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Eva Samuelsson, MD, PhD, Department of Public Health and Clinical Medicine, Umeå University
  • Principal Investigator: Eva Samuelsson, MD, PhD, Department of Public Health and Clinical Medicine, Umeå University
  • Principal Investigator: Göran Umefjord, MD, PhD, Department of Public Health and Clinical Medicine, Umeå University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2009

Primary Completion (Actual)

April 1, 2011

Study Completion (Actual)

April 1, 2011

Study Registration Dates

First Submitted

December 12, 2009

First Submitted That Met QC Criteria

December 12, 2009

First Posted (Estimate)

December 15, 2009

Study Record Updates

Last Update Posted (Actual)

March 2, 2022

Last Update Submitted That Met QC Criteria

February 16, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • FAS dnr 2008-0952
  • VLL 759-2008 (Other Identifier: Umeå University and County Councils of Northern Sweden)
  • VLL-68711 (Other Identifier: Umeå University and County Councils of Northern Sweden)
  • SLS 2008-21468 (Other Identifier: Swedish Society of Medicine)
  • Visare Norr Project nr 40/2009 (Other Identifier: County Councils of Northern Sweden)
  • JLL LS/1073/2008 (Other Identifier: County Council of Jämtland)
  • LVN 8160 (Other Identifier: County Council of Västernorrland)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Female Stress Urinary Incontinence

Clinical Trials on Web-based treatment with PFMT and elements of CBT

3
Subscribe